Healthcare - Biotechnology - NASDAQ - US
$ 2.87
-13.3 %
$ 62.2 M
Market Cap
-0.93
P/E
CASH FLOW STATEMENT
-19.8 M
OPERATING CASH FLOW
16.2 M
INVESTING CASH FLOW
15.8 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Aileron Therapeutics, Inc.
| Net Income | -15.7 M |
| Depreciation & Amortization | 119 K |
| Capital Expenditures | 0 |
| Stock-Based Compensation | 1.19 M |
| Change in Working Capital | -5.38 M |
| Others | -403 K |
| Free Cash Flow | -19.8 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||
| Net Income | (15.7) | (27.3) | (26.2) | (21.2) | (29.4) | (31.5) | (22.6) | (18.1) | (12.9) | (16.0) | 3.3 |
| Depreciation & Amortization | 0.1 | 0.2 | 0.1 | 0.2 | 0.2 | 0.2 | 0.1 | 0.2 | 0.3 | 0.6 | 0.8 |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | (0.2) | 1.5 | 0 | 0 | 0 |
| Stock Based Compensation | 1.2 | 2.1 | 2.3 | 1.9 | 2.1 | 3.3 | 1.7 | 0.7 | 0.6 | 0.4 | 0.1 |
| Other Operating Activities | 4 K | (0.2) | (0.2) | 95 K | (0.2) | (0.3) | 11 K | 18 K | 21 K | (1.0) | (18.8) |
| Change in Working Capital | (5.4) | 0.4 | 0.2 | (1.3) | 0.8 | 0.4 | 0.4 | 0.7 | 0.2 | (1.2) | 0.4 |
| Cash From Operations | (19.8) | (24.9) | (23.8) | (20.5) | (26.5) | (27.9) | (20.5) | (15.0) | (11.7) | (17.2) | (14.2) |
| INVESTING CASH FLOW | |||||||||||
| Capital Expenditures | 0 | 0 | (0.2) | 5 K | (0.2) | (4.4) | (0.1) | 0 | 94 K | (0.4) | 45 K |
| Other Items | 16.2 | 26.5 | (35.8) | 6.4 | (2.7) | 29.1 | (38.8) | 25 K | 10.7 | (5.9) | (4.1) |
| Cash From Investing Activities | 16.2 | 26.5 | (35.9) | 6.4 | (2.8) | 24.7 | (38.9) | 25 K | 10.6 | (6.3) | (4.2) |
| FINANCING CASH FLOW | |||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 91 K | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0.4 | 0 | 2.5 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 15.8 | 0 | 74 K | 0 | 0.2 | 42 K | (1.7) | 32.0 | (1.4) | 19.8 | 15.0 |
| Cash From Financing Activities | 15.8 | 0 | 55.7 | 15.8 | 24.0 | 2.5 | 50.6 | 32.0 | (1.4) | 19.8 | 15.0 |
| CHANGE IN CASH | |||||||||||
| Net Change In Cash | 12.1 | 1.6 | (4.0) | 1.7 | (5.3) | (0.7) | (8.9) | 16.9 | (2.4) | (3.7) | (3.3) |
| FREE CASH FLOW | |||||||||||
| Free Cash Flow | (19.8) | (24.9) | (23.9) | (20.5) | (26.6) | (32.3) | (20.7) | (15.0) | (11.8) | (17.6) | (14.2) |